LONGBOARD PHARMACEUTICALS IN (LBPH)

US54300N1037 - Common Stock

19.72  +0.47 (+2.44%)

After market: 19.72 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

2023
(2023-12-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
Revenue
0.000.000.000.00
Operating Expenses
56.76M44.80M27.84M14.40M
Research and Development
43.75M34.64M19.77M4.63M
Selling, General, and Administrative Expenses
13.01M10.16M8.07M9.77M
Operating Income
-56.76M-44.80M-27.84M-14.40M
Interest Income/Expense
2.40M840.00K60.00KN/A
Other Income/Expense
-68.00K20.00K-20.00KN/A
Income Before Taxes
-54.42M-43.95M-27.80M-14.40M
Net Income
-54.42M-43.95M-27.80M-14.40M
EBITDA
-56.75M-44.79MN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-2.39-2.56-1.93-0.85
Non GAAP EPS
-2.38-2.57-2.15N/A
 
Statistics

All data in USD

Charts